The Oklahoma House of Representatives last week approved a bill that would cap the cost of insulin for many Oklahomans with Type 1 diabetes. House Bill 1019, authored by Rep. Rande Worthen (R-Lawton) passed the floor by a 94-2 vote last Wednesday, March 10. The bill would cap the amount of copayment an individual would […]
You are unauthorized to view this page. Please Login or Subscribe
